1. Home
  2. MEDP vs CRS Comparison

MEDP vs CRS Comparison

Compare MEDP & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • CRS
  • Stock Information
  • Founded
  • MEDP 1992
  • CRS 1910
  • Country
  • MEDP United States
  • CRS United States
  • Employees
  • MEDP N/A
  • CRS N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • CRS Steel/Iron Ore
  • Sector
  • MEDP Health Care
  • CRS Industrials
  • Exchange
  • MEDP Nasdaq
  • CRS Nasdaq
  • Market Cap
  • MEDP 8.3B
  • CRS 9.4B
  • IPO Year
  • MEDP 2016
  • CRS N/A
  • Fundamental
  • Price
  • MEDP $294.90
  • CRS $234.56
  • Analyst Decision
  • MEDP Hold
  • CRS Buy
  • Analyst Count
  • MEDP 10
  • CRS 6
  • Target Price
  • MEDP $343.22
  • CRS $157.17
  • AVG Volume (30 Days)
  • MEDP 333.7K
  • CRS 834.3K
  • Earning Date
  • MEDP 07-21-2025
  • CRS 07-24-2025
  • Dividend Yield
  • MEDP N/A
  • CRS 0.34%
  • EPS Growth
  • MEDP 33.36
  • CRS 168.78
  • EPS
  • MEDP 13.09
  • CRS 7.05
  • Revenue
  • MEDP $2,156,580,000.00
  • CRS $2,920,100,000.00
  • Revenue This Year
  • MEDP $5.59
  • CRS $7.15
  • Revenue Next Year
  • MEDP $3.46
  • CRS $9.47
  • P/E Ratio
  • MEDP $22.53
  • CRS $33.35
  • Revenue Growth
  • MEDP 9.87
  • CRS 7.38
  • 52 Week Low
  • MEDP $250.05
  • CRS $95.17
  • 52 Week High
  • MEDP $459.77
  • CRS $238.94
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 46.73
  • CRS 66.00
  • Support Level
  • MEDP $293.51
  • CRS $219.58
  • Resistance Level
  • MEDP $302.32
  • CRS $238.94
  • Average True Range (ATR)
  • MEDP 9.27
  • CRS 7.71
  • MACD
  • MEDP -0.39
  • CRS -0.50
  • Stochastic Oscillator
  • MEDP 33.56
  • CRS 83.34

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

Share on Social Networks: